ACAD
31.75
-0.53
-1.64%
AEMD
0.26
-0.02
-6.08%
APRI
1.23
+0.02
+1.23%
ARNA
4.77
+0.15
+3.14%
ATEC
1.31
-0.04
-2.96%
CFN
59.74
-0.07
-0.12%
CNAT
6.1
+0.35
+6.10%
CRXM
0.2
0.00
-0.01%
CYTX
0.5
+0.00
+0.54%
DXCM
62.39
-0.39
-0.62%
GNMK
13.53
+0.25
+1.88%
HALO
14.49
+0.05
+0.35%
ILMN
203.04
+1.36
+0.67%
INNV
0.2
-0.03
-11.16%
INO
8.96
+0.08
+0.88%
ISCO
0.06
0.00
0.00%
ISIS
72.35
-0.55
-0.75%
LGND
58.75
+2.19
+3.87%
LPTN
2.92
0.00
0.00%
MBVX
1.11
-0.06
-5.13%
MEIP
3.68
0.00
0.00%
MNOV
3.45
-0.14
-3.90%
MRTX
21
+1.1
+5.53%
MSTX
0.46
-0.01
-2.13%
NBIX
33.5
-0.05
-0.15%
NUVA
46.96
+0.13
+0.28%
ONCS
0.39
0.00
-0.88%
ONVO
6.63
-0.12
-1.72%
OREX
5.69
+0.13
+2.34%
OTIC
34.48
+2.58
+8.09%
QDEL
24.97
+0.28
+1.13%
RCPT
116.79
+1.05
+0.91%
RGLS
18.89
-0.53
-2.73%
RMD
65.2
-1.97
-2.93%
SCIE
0.01
0.00
0.00%
SPHS
0.47
+0.00
+0.17%
SRNE
10.59
0.00
0.00%
TROV
5.99
+0.09
+1.53%
VICL
1.04
-0.04
-3.70%
VOLC
17.97
-0.01
-0.06%
ZGNX
1.39
+0.06
+4.51%
Home » Archive by Category

News

San Diego biotech news from BioSpace, Xconomy, PR Newswire, Marketwired and other sources, click on headlines to read the full story.

Arena Pharmaceuticals, Inc. Announces Agreement To Sell Common Stock

January 20, 2015 – 5:00 pm | Edit Post

SAN DIEGO, Jan. 21, 2015 /PRNewswire/ — Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) today announced that it has sold 21,000,000 shares of common stock to Jefferies LLC and Piper Jaffray & Co. as underwriters for its previously announced public offe…

TriLink BioTechnologies Grants ResearchReward For Development Of mRNA Delivery Method

January 20, 2015 – 5:00 pm | Edit Post

SAN DIEGO (January 21, 2015) TriLink BioTechnologies (TriLink) has announced Dr. Yizhou Dong, Assistant Professor at Ohio State University, has been granted a ResearchReward. Dr. Dongs ResearchReward provides stocked messenger RNA (mRNA) for research …

TrovaGene, Inc. Expands Collaboration With Genomac To Demonstrate Clinical Utility In Lung And Colorectal Cancer Treatment Monitoring

January 20, 2015 – 5:00 pm | Edit Post

SAN DIEGO, Jan. 21, 2015 /PRNewswire/ — Trovagene, Inc. (NASDAQ: TROV), today announced it will expand the clinical collaboration with Genomac Research Institute in Prague, Czech Republic. Trovagene Precision Cancer Monitoring SM technology will be us…

TriLink BioTechnologies Grants ResearchReward For Development Of mRNA Delivery Method

January 20, 2015 – 5:00 pm | Edit Post

SAN DIEGO (January 21, 2015) TriLink BioTechnologies (TriLink) has announced Dr. Yizhou Dong, Assistant Professor at Ohio State University, has been granted a ResearchReward. Dr. Dongs ResearchReward provides stocked messenger RNA (mRNA) for research …

Illumina Announces First Targeted Next-Generation Sequencing Solution For Forensic Genomics

January 20, 2015 – 5:00 pm | Edit Post

SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ: ILMN) today announced the launch of the MiSeq FGx Forensic Genomics System, the first fully validated forensic next-generation sequencing (NGS) system, which simultaneously interrogates short tandem r…

Arena Pharmaceuticals, Inc. Announces Agreement To Sell Common Stock

January 20, 2015 – 5:00 pm | Edit Post

SAN DIEGO, Jan. 21, 2015 /PRNewswire/ — Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) today announced that it has sold 21,000,000 shares of common stock to Jefferies LLC and Piper Jaffray & Co. as underwriters for its previously announced public offe…

Applied Spectral Imaging (ASI) Grabs FDA Approval for GenASIs HiPath Image Capture and Analysis Platform

January 20, 2015 – 5:00 pm | Edit Post

Applied Spectral Imaging (ASI) Receives FDA Clearance for GenASIs™ HiPath IHC Family for HER2, ER, PR and Ki67

CARLSBAD, Calif.–(BUSINESS WIRE)–Applied Spectral Imaging (ASI, www.spectral-imaging.com) announced today that it has received clearance from the U.S. Food and Drug Administration (FDA) for its GenASIs HiPath image capture and analysis platform…

TrovaGene, Inc. Expands Collaboration With Genomac To Demonstrate Clinical Utility In Lung And Colorectal Cancer Treatment Monitoring

January 20, 2015 – 5:00 pm | Edit Post

SAN DIEGO, Jan. 21, 2015 /PRNewswire/ — Trovagene, Inc. (NASDAQ: TROV), today announced it will expand the clinical collaboration with Genomac Research Institute in Prague, Czech Republic. Trovagene Precision Cancer Monitoring SM technology will be us…

Synthetic Genomics, Inc. Release: SGI-DNA Launches Gibson Assembly?? Ultra Kit For Robust, Seamless And Efficient Construction Of Synthetic Genes, Genetic Pathways And Whole Genomes

January 20, 2015 – 5:00 pm | Edit Post

LA JOLLA, Calif., Jan. 21, 2015 /PRNewswire/ –SGI-DNA announces the launch of the Gibson Assembly Ultra Kit which allows researchers to perform complex, large, and multiple fragment assemblies in a simple, two-step reaction.

Cytori Therapeutics, Inc. And Leading Expert Discuss Importance Of “STAR” Trial And Treatment For Scleroderma Patients

January 20, 2015 – 5:00 pm | Edit Post

SAN DIEGO–(BUSINESS WIRE)–Cytori Therapeutics, Inc. (NASDAQ: CYTX) announced today that information, presented last week in San Francisco, introducing its pivotal scleroderma trial (the STAR trial), is now available on the company website at www.Cyto…